CIK 0000031791 · Large accelerated filer
REVVITY, INC.
Sign in to watch- Ticker
- RVTY
- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 29
- Incorporated
- MA
- Entity type
- operating
- EIN
- 042052042
- Phone
- 781-663-6900
- Business address
- 77 4TH AVENUE, WALTHAM, MA, 02451
- Former names
- PERKINELMER INC, EG&G INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,281,439
- in 3 filings, $1.3M under 10b5-1 plans
Net −$1,281,439. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-04 | Goldberg Joel S Please See Remarks | Grant or award | +4,939 | 37,689 | ||
| 2025-02-04 | Goldberg Joel S Please See Remarks | Grant or award · NQ Stock Option (right to buy) | +13,656 | 13,656 | ||
| 2025-02-04 | Singh Prahlad R. Please See Remarks | Shares withheld for taxes | −4,857 | $123.69 | $601K | 85,338 |
| 2025-02-04 | Singh Prahlad R. Please See Remarks | Grant or award | +20,920 | 106,258 | ||
| 2025-02-04 | Singh Prahlad R. Please See Remarks | Grant or award · NQ Stock Option (right to buy) | +57,838 | 57,838 | ||
| 2025-02-04 | Krakowiak Maxwell Please See Remarks | Grant or award | +5,709 | 12,826 | ||
| 2025-02-04 | Krakowiak Maxwell Please See Remarks | Grant or award · NQ Stock Option (right to buy) | +15,784 | 15,784 | ||
| 2025-02-04 | Vohra Tajinder S Please See Remarks | Shares withheld for taxes | −307 | $123.69 | $38K | 19,345 |
| 2025-02-04 | Vohra Tajinder S Please See Remarks | Grant or award | +3,280 | 22,625 | ||
| 2025-02-04 | Vohra Tajinder S Please See Remarks | Grant or award · NQ Stock Option (right to buy) | +9,069 | 9,069 | ||
| 2025-01-30 | Goldberg Joel S Please See Remarks | Option exercise 10b5-1 | +15,170 | $81.29 | $1.2M | 48,570 |
| 2025-01-30 | Goldberg Joel S Please See Remarks | Sale 10b5-1 | −500 | $124.45 | $62K | 48,070 |
| 2025-01-30 | Goldberg Joel S Please See Remarks | Sale 10b5-1 | −2,710 | $125.99 | $341K | 45,360 |
| 2025-01-30 | Goldberg Joel S Please See Remarks | Sale 10b5-1 | −10,660 | $126.90 | $1.4M | 34,700 |
| 2025-01-30 | Goldberg Joel S Please See Remarks | Sale 10b5-1 | −1,300 | $127.77 | $166K | 33,400 |
| 2025-01-30 | Goldberg Joel S Please See Remarks | Option exercise · NQ Stock Option (right to buy) 10b5-1 | −15,170 | 0 | ||
| 2025-01-07 | Vohra Tajinder S Please See Remarks | Option exercise 10b5-1 | +5,492 | $81.29 | $446K | 25,144 |
| 2025-01-07 | Vohra Tajinder S Please See Remarks | Sale 10b5-1 | −2,430 | $116.13 | $282K | 22,714 |
| 2025-01-07 | Vohra Tajinder S Please See Remarks | Sale 10b5-1 | −2,388 | $117.14 | $280K | 20,326 |
| 2025-01-07 | Vohra Tajinder S Please See Remarks | Sale 10b5-1 | −474 | $117.79 | $56K | 19,852 |
Page 7 of 12 · 231 trades